Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?

Published Aug 17, 2020

Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?

Comprehensive biomarker testing is genetic testing of a lung tumor that tells doctors whether targeted therapy will work.

NOW
PLAYING
87% of Eligible Patients Skip Lung Cancer Screening, Analysis Finds
NOW
PLAYING
'Raindrops Keep Fallin' on My Head' Singer B.J. Thomas, 78, Dies From Stage 4 Lung Cancer
NOW
PLAYING
Actor Ben Platt Gives a Two-Time Brain Cancer Survivor a Big Surprise
NOW
PLAYING
Netflix's 'Halston' Shines a Light on the Designer Who Died from Lung Cancer
NOW
PLAYING
All Americans Should Begin Colorectal Cancer Screening at Age 45, According to New Guidelines; Previous Age Was 50
NOW
PLAYING
Cancer Patients Should Still Wear Masks & Distance Says Leading Expert - Even in Wake of Major New CDC Guidelines
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.